Laboratorios Farma | ROVI - Ebit

Stock Price
78.20
Daily Change
0.25 0.32%
Monthly
7.64%
Yearly
41.80%
Q1 Forecast
76.56

Laboratorios Farma reported EUR135.05M in EBIT for its fiscal semester ending in December of 2023.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Almirall EUR 30.23M 12.8M Dec/2025
Avita Medical AUD -8.66M 1.61M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Pharma Mar EUR -3.96M 28.11M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025